SCIORTINO, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 1.505
AS - Asia 826
SA - Sud America 529
EU - Europa 278
AF - Africa 41
Totale 3.179
Nazione #
US - Stati Uniti d'America 1.453
BR - Brasile 466
SG - Singapore 358
CN - Cina 157
HK - Hong Kong 78
VN - Vietnam 78
FI - Finlandia 57
UA - Ucraina 42
DE - Germania 37
FR - Francia 32
IT - Italia 30
AR - Argentina 27
TR - Turchia 23
IN - India 21
MX - Messico 21
IQ - Iraq 20
CA - Canada 19
GB - Regno Unito 19
BD - Bangladesh 17
ZA - Sudafrica 17
PL - Polonia 14
EC - Ecuador 11
KR - Corea 11
SE - Svezia 11
JP - Giappone 10
ID - Indonesia 9
NL - Olanda 9
JO - Giordania 8
VE - Venezuela 8
ES - Italia 7
MA - Marocco 7
UZ - Uzbekistan 7
CO - Colombia 6
RU - Federazione Russa 6
PK - Pakistan 5
HN - Honduras 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BE - Belgio 3
CL - Cile 3
KE - Kenya 3
NP - Nepal 3
PH - Filippine 3
PY - Paraguay 3
AO - Angola 2
AZ - Azerbaigian 2
CG - Congo 2
DO - Repubblica Dominicana 2
IE - Irlanda 2
JM - Giamaica 2
MY - Malesia 2
PA - Panama 2
PE - Perù 2
SN - Senegal 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
HU - Ungheria 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
MN - Mongolia 1
NA - Namibia 1
NI - Nicaragua 1
OM - Oman 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
YT - Mayotte 1
Totale 3.179
Città #
Dallas 454
Chandler 209
San Jose 193
Singapore 183
Ashburn 80
Hong Kong 77
Beijing 60
Princeton 38
Helsinki 34
São Paulo 29
Lauterbourg 28
Ho Chi Minh City 26
Shanghai 23
Hanoi 21
Santa Clara 21
Council Bluffs 20
Los Angeles 19
New York 17
Mountain View 15
Orem 15
Wilmington 14
Falkenstein 13
Rio de Janeiro 13
The Dalles 12
Warsaw 12
Belo Horizonte 10
Columbus 10
Brasília 9
Espoo 9
Seoul 9
Tokyo 9
Amman 8
Denver 8
Frankfurt am Main 8
Johannesburg 8
Atlanta 7
Lappeenranta 7
Phoenix 7
Querétaro 7
Salvador 7
Toronto 7
Baghdad 6
Coventry 6
Jakarta 6
Montreal 6
Porto Alegre 6
San Francisco 6
Tashkent 6
Turku 6
Boardman 5
Campinas 5
Cape Town 5
Chennai 5
Curitiba 5
Osasco 5
Quartucciu 5
Recife 5
Santo André 5
Stockholm 5
Amsterdam 4
Ankara 4
Diadema 4
Florianópolis 4
Guarulhos 4
Guayaquil 4
Haiphong 4
Istanbul 4
Maringá 4
Mexico City 4
Munich 4
Nuremberg 4
Poplar 4
Rome 4
Sorocaba 4
Sumaré 4
Ann Arbor 3
Barbianello 3
Brussels 3
Bắc Ninh 3
Campo Grande 3
Caracas 3
Chicago 3
Da Nang 3
Erbil 3
Franca 3
Jacksonville 3
Kilis 3
London 3
Manaus 3
Manchester 3
Marília 3
Mauá 3
Montes Claros 3
Nairobi 3
Nanchang 3
Ottawa 3
Quito 3
Ribeirão Preto 3
Riyadh 3
São Bernardo do Campo 3
Totale 1.993
Nome #
Covalent and non-covalent binding in vanadium–protein adducts 138
Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction 138
DFT Protocol for EPR Prediction of Paramagnetic Cu(II) Complexes and Application to Protein Binding Sites 131
ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins 129
Biospeciation of Potential Vanadium Drugs of Acetylacetonate in the Presence of Proteins 127
Binding of potential antitumor Casiopeínas® to small proteins 125
Binding of VIV O2+ , VIV OL, VIV OL2 and VV O2 L Moieties to Proteins: X-ray/Theoretical Characterization and Biological Implications 118
Rationalizing the Decavanadate(V) and Oxidovanadium(IV) Binding to G-Actin and the Competition with Decaniobate(V) and ATP 117
Effect of secondary interactions, steric hindrance and electric charge on the interaction of VIVO species with proteins 114
Unveiling VIVO2+ Binding Modes to Human Serum Albumins by an Integrated Spectroscopic–Computational Approach 109
A Series of Non-Oxido VIVComplexes of Dibasic ONS Donor Ligands: Solution Stability, Chemical Transformations, Protein Interactions, and Antiproliferative Activity 105
Mo(VI) Potential Metallodrugs: Explaining the Transport and Cytotoxicity by Chemical Transformations 105
Protein‐Protein Stabilization in VIVO/8‐Hydroxyquinoline–Lysozyme Adducts 101
New VIV, VIVO, VVO, and VVO2Systems: Exploring their Interconversion in Solution, Protein Interactions, and Cytotoxicity 100
Solution chemistry of oxidovanadium(IV) complexes with two bis-kojic acid derivatives 99
Quantitative prediction of electronic absorption spectra of copper(II)–bioligand systems: Validation and applications 99
Binding of vanadium ions and complexes to proteins and enzymes in aqueous solution 97
Polyoxovanadates with emerging biomedical activities 94
Through-Space Spin Coupling in a Silver(II) Porphyrin Dimer upon Stepwise Oxidations: AgII⋅⋅⋅AgII, AgII⋅⋅⋅AgIII, and AgIII⋅⋅⋅AgIII Metallophilic Interactions 92
Integrated experimental/computational approaches to characterize the systems formed by vanadium with proteins and enzymes 89
Experimental and Computational Studies on the Interaction of DNA with Hesperetin Schiff Base CuII Complexes 88
Implications of Protein Interaction in the Speciation of Potential VIVO-Pyridinone Drugs 85
Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes 84
Stepwise Oxidations in a Cofacial Copper(II) Porphyrin Dimer: Through-Space Spin-Coupling and Interplay between Metal and Radical Spins 84
Ferromagnetic Coupling in Oxidovanadium(IV)-Porphyrin Radical Dimers 84
Interaction of VIVO–8-hydroxyquinoline species with RNase A: the effect of metal ligands in the protein adduct stabilization 82
Multiple and Variable Binding of Pharmacologically Active Bis(maltolato)oxidovanadium(IV) to Lysozyme 78
New mixed ligand oxidovanadium(IV) complexes: Solution behavior, protein interaction and cytotoxicity 76
Promising anticancer agents based on 8-hydroxyquinoline hydrazone copper(II) complexes 74
Interaction with CT-DNA and in vitro cytotoxicity of two new copper(II)-based potential drugs derived from octanoic hydrazide ligands 73
Polyoxidovanadates' interactions with proteins: An overview 69
The binding modes of VIVO2+ions in blood proteins and enzymes 68
Stabilization and Binding of [V4O12]4− and Unprecedented [V20O54(NO3)]n− to Lysozyme upon Loss of Ligands and Oxidation of the Potential Drug VIVO(acetylacetonato)2 61
Totale 3.233
Categoria #
all - tutte 13.512
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.512


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202297 4 0 0 0 9 1 2 9 10 8 7 47
2022/2023332 32 42 16 57 20 48 0 42 64 1 8 2
2023/202491 18 7 4 8 20 4 0 3 4 0 10 13
2024/20251.027 4 8 45 25 23 57 102 201 316 154 66 26
2025/20261.618 57 298 287 217 162 101 254 50 65 70 48 9
Totale 3.233